AMBERLY EVERSOLE: Open Payments
NPI 1508620733 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 83 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,723 · 2025 $1,744
Food & beverage: $1,744
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $253 |
| Abbott Laboratories | 7 | $220 |
| Novo Nordisk Inc | 11 | $204 |
| SANOFI-AVENTIS U.S. LLC | 5 | $172 |
| Dexcom, Inc. | 17 | $164 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $110 |
| Insulet Corporation | 4 | $95 |
| Lilly USA, LLC | 5 | $82 |
| Radius Health, Inc. | 3 | $79 |
| Medtronic, Inc. | 1 | $75 |
Products named: REPATHA, TZIELD, Dexcom G6 Transmitter, Ozempic, FREESTYLE LIBRE, ISTURISA, FREESTYLE LIBRE 3, Omnipod.
Industry payments across MO — which companies pay providers there.
